Home About us Contact
|
Home About us Contact | ||
|
|
||
Addiction
Kinds of Addiction Terms modified by Addiction Selected AbstractsOBESITY AND NUTRIENT CONSUMPTION: A RATIONAL ADDICTION?CONTEMPORARY ECONOMIC POLICY, Issue 3 2007TIMOTHY J. RICHARDS Recent research shows that the dramatic rise in obesity in the United States is due more to the overconsumption of unhealthy foods than underactivity. This study tests for an addiction to food nutrients as a potential explanation for the apparent excessive consumption. A random coefficients (mixed) logit model is used to test a multivariate rational addiction model. The results reveal a particularly strong addiction to carbohydrates. The implication of this finding is that price-based policies, sin taxes, or produce subsidies that change the expected future costs and benefits of consuming carbohydrate-intensive foods may be effective in controlling excessive nutrient intake. (JEL D120, I120, C230) [source] WHAT INTEGRATED INTERDISCIPLINARY AND TRANSLATIONAL RESEARCH MAY TELL US ABOUT ADDICTIONADDICTION, Issue 5 2010MARC N. POTENZA No abstract is available for this article. [source] WHAT NEUROBIOLOGY TELLS US ABOUT ADDICTIONADDICTION, Issue 5 2010MARTIN Y. IGUCHI No abstract is available for this article. [source] MOBILE PHONE ADDICTION: A POINT OF ISSUEADDICTION, Issue 2 2010MARIANO CHÓLIZ No abstract is available for this article. [source] WHAT WE DO AND DO NOT KNOW ABOUT ADDICTIONADDICTION, Issue 1 2010RUTGER C. M. E. ENGELS No abstract is available for this article. [source] SCIENCE WILL UNCOVER THE MYSTERIES OF ADDICTION IN THE ENDADDICTION, Issue 1 2010DOUG SELLMAN No abstract is available for this article. [source] IMPLICATIONS OF THE MULTIPLE-VULNERABILITIES THEORY OF ADDICTION FOR CRAVING AND RELAPSEADDICTION, Issue 11 2009A. DAVID REDISH No abstract is available for this article. [source] FRAGMENTED INTIMACY: ADDICTION IN A SOCIAL WORLDADDICTION, Issue 4 2009TOM WALKER No abstract is available for this article. [source] [Commentary] IS THIS A BREAKTHROUGH IN PSYCHOLOGICAL TREATMENT OF ADDICTION, OR ARE MOMMY AND I ONE AGAIN?ADDICTION, Issue 12 2008PETER HAJEK No abstract is available for this article. [source] [Commentary] WHY WE DO WHAT WE DO,DELIVERY OF BUPRENORPHINE AND THE TREATMENT OF OPIOID ADDICTIONADDICTION, Issue 12 2007WALTER LING No abstract is available for this article. [source] HEPATITIS C AND ADDICTION: Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addictionADDICTION BIOLOGY, Issue 2 2009Albert S. Reece ABSTRACT Intravenous drug addiction is known to be associated with an inordinate morbidity and mortality. As our previous report had identified an immune phenotype consistent with accelerated ageing, we wished to investigate how much of this change may have been related to chronic viral hepatitis. A total of 12 409 clinical pathology results from the period 1995,2007 were reviewed. To control for the differences in age, only patients less than 48 years of age were considered. A total of 636 substance use disorder (SUD) and 6103 non-SUD (N-SUD) patients were studied. They had comparable ages (mean ± SD 31.32 ± 6.90 versus 31.57 ± 9.23, P -value not significant), but the SUD group had more males (74.37% versus 53.20%, P < 0.001). For most of the changes examined splitting the two SUD groups into hepatitis C positive (HCV+) and hepatitis C negative (HCV,) demonstrated that the majority of the described changes were most marked in the HCV+ group. The globulins were higher in the HCV+ group and the albumin was lower and fell more markedly with age than in N-SUD or HCV, (all P < 0.001). The globulin/albumin ratio was significantly higher in HCV+ than HCV, or N-SUD (both P < 0.0001) and rose more with age. These changes were paralleled by the ESR, elevations in the CRP and lymphocyte count. Transaminases were elevated in SUD and HCV+ groups compared with N-SUD (all P < 0.02). At multivariate analysis ESR, lymphocyte count, dual hepatitis B and C seropositivity, AST and HCVAb were significant predictors of the serum globulin level and accounted for 21% of the variance. These data extend our earlier report and show that much of the immunosenescent phenotype of SUD, encompassing the known immunosuppression and the observed immunostimulation, is statistically related to chronic viral hepatitis. Important theoretical and practical management (vaccination) implications ensue. [source] HEPATITIS C AND ADDICTION: Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patientsADDICTION BIOLOGY, Issue 2 2009Nina Ebner ABSTRACT Hepatitis C viral (HCV) infection is present in 30 to 98% of intravenous drug users. Intravenous substance abuse represents the main route of HCV transmission in industrialized countries. A multi-centre, randomized, controlled, prospective study assessed sustained virological response (SVR), adverse events such as depressive episodes and retention rate of HCV treatment in opioid-dependent patients. Stabilized, opioid-dependent patients with chronic HCV infection (genotype 2 or 3) received pegylated interferon alpha-2a in combination with ribavirin 800 mg/day (Group A) or 400 mg/day (Group B). Participants were randomized, blocked and stratified by genotype and viral load. A standardized psychiatric assessment, Beck Depression Inventory (BDI) and Van Zerssen's list of complaints were administered at each study visit. In 31 months, 300 opioid-dependent patients were screened; 190 (63.3%) were hepatitis C antibody positive. According to study protocol, out of 75 ,potential-to-treat' patients with genotype 2 or 3, 17 stable patients (22.6%) were included in the study. All participants completed the study. Significant haemoglobin decreases occurred in both Groups A (P = 0.001) and B (P = 0.011). All the patients had an end-of-treatment (week 24) HCV RNA negativity. Fifteen (88.2%) achieved SVR at week 48. Overall, 52.9% developed depressive symptoms during treatment. Because of the prompt initiation of antidepressant medication at first appearance of depressive symptoms, no severe depressive episodes occurred. Our data show a high retention rate and reliability, and good viral response for both treatments. Hepatitis C treatment in stable opioid-dependent patients was efficacious, suggesting that addiction clinics can offer antiviral therapy in combination with agonistic treatment as part of multi-disciplinary treatment. [source] SEXUAL ADDICTION AND MARRIAGE AND FAMILY THERAPY: FACILITATING INDIVIDUAL AND RELATIONSHIP HEALING THROUGH COUPLE THERAPYJOURNAL OF MARITAL AND FAMILY THERAPY, Issue 3 2006Mark H. Bird In recent decades there has been an increase in literature regarding sexual addiction as well as a growing number of clients presenting in therapy with problems related to their sexual behaviors (including internet sexual addiction). This article (a) presents a synthesis of the research on the impact of sexual addiction on the addict, the partner, and the couple; (b) outlines the process of healing for each based on the research synthesis; and (c) discusses the role of marriage and family therapy in facilitating both individual and relationship healing from sexual addiction. Implications for future research in sexual addiction, generally, and in marriage and family therapy, specifically, are presented. [source] ADDICTION ADDICTION ADDICTION ADDICTIONTHE BROWN UNIVERSITY DIGEST OF ADDICTION THEORY AND APPLICATION, Issue S1 2007Article first published online: 19 DEC 200 No abstract is available for this article. [source] RESPONSE TO COMMENTARIES ON ,WHAT NEUROBIOLOGY CANNOT TELL US ABOUT ADDICTION'ADDICTION, Issue 5 2010HAROLD KALANT No abstract is available for this article. [source] Women & Addiction: A Comprehensive HandbookDRUG AND ALCOHOL REVIEW, Issue 3 2010Gail Gilchrist No abstract is available for this article. [source] Methamphetamine Addiction: Biological FoundationsDRUG AND ALCOHOL REVIEW, Issue 2 2010Rebecca McKetin No abstract is available for this article. [source] Addiction: a chronic medical conditionDRUG AND ALCOHOL REVIEW, Issue 4 2008Mph Director, Robert G. Newman Md No abstract is available for this article. [source] Working memory and multi-tasking in paranoid schizophrenia with and without comorbid substance use disorderADDICTION, Issue 5 2008Patrizia Thoma ABSTRACT Aims Addiction is a frequent comorbid disorder in schizophrenia and associated with poor outcome. The present study sought to determine whether addicted and non-addicted schizophrenic patients are impaired differentially on the executive abilities of working memory and multi-tasking which are relevant for maintaining abstinence. Design Comparisons of executive performance in clinical and control groups. Setting In-patient setting. Participants The cognitive profile of schizophrenic patients with and without comorbid substance abuse disorder was compared with that of patients suffering from major depression or alcoholism and healthy participants. Measurements A range of cognitive tasks was used to assess: (i) the ability to update continuously context information in working memory and to use it for action selection; and (ii) the capacity to divide attention between different sensory input channels and to coordinate verbal and manual responses. Findings Single-diagnosis schizophrenic patients showed pronounced impairments on measures of online maintenance and use of context information. Their ability to coordinate different sensory input channels (divided attention) was also impaired. Addicted schizophrenics showed evidence of impaired sensory input management and of reduced context sensitivity, when age differences were controlled. Conclusions The present study indicates severe working memory and multi-tasking deficits in schizophrenia which are, however, not exacerbated by comorbid addiction. [source] Addiction to apomorphine: a clinical case-centred discussionADDICTION, Issue 11 2006Carlos Téllez ABSTRACT Aim To report the case of a patient, who in the context of an anti-Parkinsonian therapy, developed addiction to apomorphine. Methods Clinical case description. Results Apomorphine is a dopaminergic agonist that acts directly on D2 receptors. It has been used in alcoholism, male sexual dysfunction and with diagnostic and therapeutic purposes in Parkinson's disease (PD). Conclusions The present work describes the case of a woman with PD who developed a loss of control over the consumption of apomorphine that resulted in a significant impairment of her functioning. PD patients with high frequency develop different psychiatric symptoms. Conversely, anti-Parkinsonian drugs also generate psychiatric symptoms that can be experienced by the patient as pleasant sensations (,alerting', ,awakening', ,activating', hypomania and hypersexuality). In spite of this, addiction to these drugs in patients with PD is a very rare phenomenon. Currently, the prescription of apomorphine has been extended to patients with erectile dysfunction, which may increase the prevalence of addiction cases or of severe psychiatric symptoms. [source] Addiction: a journal and its Invisible College,ADDICTION, Issue 5 2006Griffith Edwards ABSTRACT Provenance This paper derives from a lecture given before the Society for the Study of Addiction in November 2004, on the author's retirement from the position of Editor-in-Chief of Addiction, one of the Society's journals. Aim To identify the live processes which have influenced the journal's evolution since its foundation in 1884. Conclusions Over the 120-year period a strong, continuing historical thread has been the fluctuating success of the journal's engagement with its ,Invisible College', the community which it seeks to serve. It is argued that the journal's future success will depend on its capacity to explore and nurture further this two-way relationship. Addiction is a journal with an active and clearly articulated, multiple vision of it purpose, and this vision is outlined. It dares to try to influence its future with the authority so to do rooted in its ability to reflect the aspirations and concerns of its readers. It is ,a journal of the second kind'. [source] European Union scientific production on alcohol and drug misuse (1976,2000)ADDICTION, Issue 8 2005Xavier Sánchez-Carbonell ABSTRACT Background Alcohol and drug misuse is a social and health phenomenon of great relevance in the European Union (EU). One indicator of scientific production in a given area is the analysis of publications included in bibliographic databases. Scientific production on alcohol and drug misuse was analysed in EU member countries, and comparisons were made between countries. Methods Analysis of articles on alcohol and drug misuse published during the period 1976,2000 by institutions based in a country of the EU, indexed by PsycINFO. Results A total of 4825 citations was retrieved. Great Britain published 38.6%, while Sweden, Germany and Spain accounted for a further 30%. The articles dealt with drug and alcohol usage (12.8%), substance abuse (53.5%) and drug and alcohol rehabilitation (34.5%). The articles were published in 13 different languages, more than three-quarters being in English. Spanish was the second language, and was followed by French, German, Dutch and Italian. The articles were published in 521 different journals, and 62 of these published more than 10 articles. The journals publishing most were Addiction, Alcohol and Alcoholism and Drug and Alcohol Dependence. Sixty-eight per cent of the articles were signed by more than one author, and the index of collaboration, between 1996 and 2000, was 3.24. Discussion and conclusions PsycINFO is useful for making comparisons between countries, because it includes the name and country of the institution. The number of publications in the EU on alcohol and drug misuse increased over the quarter-century analysed. The most used language was English, as it also is for PsycINFO as a whole, and a tendency towards its increased use was observed. Classification of the articles by subject by the Classification Code is too general, and makes it difficult to distinguish between the areas it proposes. Production tends to be concentrated in journals dealing specifically with drug dependence and psychiatry. The index of collaboration is similar to that found in other scientific areas. [source] ,A good read': a new editor for Addiction but the same philosophyADDICTION, Issue 1 2005ROBERT WEST Editor-in-Chief Addiction No abstract is available for this article. [source] Maintenance Treatment of Heroin Addiction.ADDICTION, Issue 10 2004Evidence at the Crossroads No abstract is available for this article. [source] Methadone Matters: Evolving Community Methadone Treatment of Opiate AddictionADDICTION, Issue 4 2004ALEX WODAK No abstract is available for this article. [source] Addiction and Change: How Addictions Develop and Addicted People RecoverADDICTION, Issue 12 2003STEVE ALLSOP No abstract is available for this article. [source] Addiction: Evolution of a Specialist FieldADDICTION, Issue 9 2003PETER ANDERSON Consultant No abstract is available for this article. [source] High Culture: Reflections on Addiction and ModernityADDICTION, Issue 9 2003AMBROS UCHTENHAGEN No abstract is available for this article. [source] Addiction, ethics and scientific freedomADDICTION, Issue 7 2003WAYNE HALL No abstract is available for this article. [source] No switching off the camera: how Addiction will respond to infringements of ethical publishing expectationADDICTION, Issue 10 2001Griffith Edwards First page of article [source] | |||||||||||||||||||||||||||||||||||||||||||